Panel
How Patients Can—and Must—Disrupt Traditional Pharma Clinical Trials
Tue, Feb 4, 2025 · 9:20–9:50 AM EST Rosen Shingle Creek
About this session
Keynote Panel Discussion.
Should biopharma companies be the only "sponsors" for clinical trials of new medicines? Does the current model limit opportunities for unmet needs in small populations or leveraging repurposed drugs? This panel will gather leaders demonstrating ways that patient-led non-profit organizations are challenging assumptions and taking a leadership position in medicine development. No longer can we think of patients as guests at pharma's table—is the next transformation in medicine development going to be entirely patient-led?
Speakers
-
Senior Program Manager, Science in Society and Lead, Rare As One Network · Chan Zuckerberg Initiative LLC
Panelist
